Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

October 31, 2014

Conditions
Acute Deep Venous Thrombosis of the Lower Extremity
Interventions
DRUG

Alteplase (Activase, Genentech)

Dose of Alteplase will not exceed 10 mg/d/leg and is delivered in a concentration of 100ug/mL. The actual dose delivered is based upon the length of the thrombosed vein and 1 mL is injected directly into each centimeter of a thrombosed vein in a lower extremity. The treatment will be repeated up to 4 times over a 4 day period.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

National Institutes of Health Clinical Center (CC)

NIH

lead

Richard Chang, M.D.

NIH

NCT00082355 - Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins | Biotech Hunter | Biotech Hunter